Your challenge: Need to adapt your marketing strategies to fit Japan’s changing market?
Japan has the potential for massive sales but relying on other market strategies will not translate. What worked in the past may not automatically work any longer as Japan is at a crossroads and her unique system is being stressed and strained by the following changes:
- Low growth rate due to MHLW bi-annual price cuts
- Threat of this price cut being stepped up to annually with proposed changes to the Pharmaceutical Affairs Law (PAL)
- Long drug approval times, although changes in the approval system should speed this up
- Healthcare reform proposals, including increasing co-payment levels
- Japanese government encouraging increased generic substitution by introducing schemes in which physicians are permitted to stamp ‘substitution allowed’ on the prescriptions they write
- Japanese government also promoting use of generics in hospitals throughout Japan
- MHLW study into safety and efficacy of generics to prove that they are as good as branded
- Non-availability of many leading products
Are you:
- concerned about how to get the correct facts required to support your decision making?
- justifying budget decisions with little evidence?
- relying on second hand data or ‘gut feel’?
Our solution
94.8 presents depth and granularity for Japan’s market data by ensuring the data used is collected at the time of the analytics. We ensure high quality by not using second-hand data but collecting our own, verified, meticulously processed and incisive facts and figures. We have completed numerous projects in Japan in the past five years in both primary and secondary care and understand the complexities of this marketplace. We also have an office in Tokyo to support your team on the ground.
You’ll know:
- the key drivers in this market for your therapeutic area
- the key drivers based on the unique Japanese market challenges (e.g. biannual price cutting etc)
- the key driver messages by doctor segment and indication in that market
- the key driver channels by doctor segment and indication in that market
- what really influences prescribers to continue or change prescribing behavior
- how to allocate resources and budgets across channels, segments, indications, brands and even across regions for maximum return
- the core changes needed to accelerate growth for your brand
- where the best market opportunities lie and how to access them
Eularis has conducted many projects in Japan and even has our Portal fully in Japanese to assist Japanese teams fully.